- €65.96m
- €48.97m
- €53.79m
- 98
- 79
- 52
- 94
Annual income statement for Doccheck AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 63.1 | 85.9 | 60.9 | 53.4 | 53.8 |
| Cost of Revenue | |||||
| Gross Profit | 40.3 | 49.7 | 45.8 | 43.2 | 42.6 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 49.3 | 69.3 | 50.5 | 49.9 | 47.2 |
| Operating Profit | 13.8 | 16.6 | 10.4 | 3.54 | 6.61 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 13.9 | 17.3 | 9.32 | 4.38 | 7.56 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 9.61 | 11.8 | 6.27 | 2.13 | 5.28 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 9.2 | 11.4 | 6.29 | 2.27 | 5.28 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 9.2 | 11.4 | 6.29 | 2.27 | 5.28 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.88 | 2.3 | 1.28 | 0.475 | 1.07 |
| Dividends per Share |